| Product Code: ETC11944639 | Publication Date: Apr 2025 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The import trend of endoscopy devices for obesity, type II diabetes, and NASH in the Bahamas from 2020 to 2024 exhibited a compound annual growth rate (CAGR) of 0.04%. Notably, there was a significant year-on-year growth rate of -45.92% from 2023 to 2024. These figures indicate an overall increase in imports of these medical devices during the specified period.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Overview |
3.1 Bahamas Country Macro Economic Indicators |
3.2 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, 2022 & 2032F |
3.3 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Industry Life Cycle |
3.4 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Porter's Five Forces |
3.5 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Procedure, 2022 & 2032F |
3.7 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Disease Indication, 2022 & 2032F |
4 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of obesity, type II diabetes, and non-alcoholic steatohepatitis (NASH) in the Bahamas |
4.2.2 Technological advancements in endoscopy devices for the treatment of obesity, type II diabetes, and NASH |
4.2.3 Growing awareness about the benefits of endoscopic procedures for these conditions |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for medical devices in the Bahamas |
4.3.2 Limited healthcare infrastructure and access to specialized care in some regions |
4.3.3 High cost associated with endoscopy procedures for obesity, type II diabetes, and NASH |
5 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Trends |
6 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, By Types |
6.1 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Product, 2022 - 2032F |
6.1.3 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Endoscope, 2022 - 2032F |
6.1.4 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Mechanical endoscopic equipment, 2022 - 2032F |
6.1.5 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Visualization and documentation systems, 2022 - 2032F |
6.1.6 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Accessories, 2022 - 2032F |
6.1.7 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Other endoscopy equipment , 2022 - 2032F |
6.2 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, By Procedure |
6.2.1 Overview and Analysis |
6.2.2 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Gastric balloon, 2022 - 2032F |
6.2.3 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Aspiration therapy, 2022 - 2032F |
6.2.4 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Endoscopic sleeve gastroplasty, 2022 - 2032F |
6.2.5 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Gastric injection, 2022 - 2032F |
6.2.6 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Lap band surgery , 2022 - 2032F |
6.3 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, By Disease Indication |
6.3.1 Overview and Analysis |
6.3.2 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Obesity , 2022 - 2032F |
6.3.3 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Type II Diabetes , 2022 - 2032F |
6.3.4 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Nonalcoholic Steatohepatitis (NASH, 2022 - 2032F |
7 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Import-Export Trade Statistics |
7.1 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Export to Major Countries |
7.2 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Imports from Major Countries |
8 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Key Performance Indicators |
8.1 Patient outcomes improvement rate post-endoscopy procedures |
8.2 Adoption rate of endoscopy devices for obesity, type II diabetes, and NASH in healthcare facilities |
8.3 Average waiting time for endoscopy procedures for these conditions in the Bahamas |
8.4 Number of trained healthcare professionals proficient in using endoscopy devices for these treatments |
8.5 Complication rate associated with endoscopy procedures for obesity, type II diabetes, and NASH |
9 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Opportunity Assessment |
9.1 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Procedure, 2022 & 2032F |
9.3 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Disease Indication, 2022 & 2032F |
10 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Competitive Landscape |
10.1 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenue Share, By Companies, 2025 |
10.2 Bahamas Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here